Molecular Diagnostics: Effective Tools for Disease Management (3rd Edition)

Drug and Market Development Publishing
November 1, 2006
621 Pages - SKU: DSMD1378693
License type:
D&MD’s Molecular Diagnostics: Effective Tools for Disease Management, 3rd Edition market analysis report offers a comprehensive coverage of the scientific and technological developments which are creating new opportunities for the development of improved molecular diagnostics. This information will benefit developers of in vitro diagnostics as well as drug developers. The report analyses significant recent developments in molecular diagnostics which have implications for all developers of in vitro diagnostics and drugs. The first generation of molecular diagnostics on the market analyze protein and DNA biomarkers. New tests and services utilizing protein or DNA biomarkers continue to be launched and these are analyzed in the report.

Sreten Bogdanovic, Ph.D., and Beata Langlands, Ph.D., are co-founders of Biophoenix, a biomedical consultancy based in the heart of England, UK. Established with support from the UK Department of Trade and Industry (DTI) in 1994, Biophoenix provides detailed, accurate, market and technical information to support decision-making by biotechnology-based enterprises in the healthcare industry. In doing so, Biophoenix relies on its comprehensive in-house bioindustry database and a wide network of contacts. Biophoenix also audits biotechnology-based enterprises with regard to the risk of intellectual property litigation on behalf of several Lloyds of London insurers. Dr Bogdanovic is Managing Partner in Biophoenix. He holds a PhD in endocrinology from Imperial College, UK, and has worked as manager for immunodiagnostics with the UK subsidiary of Boehringer Mannheim (now owned by Roche), and as an independent biomedical market analyst with Cistron, UK. Dr Langlands holds a PhD in biochemistry from the University of Glasgow, UK, and has worked as an immunologist, a project leader with a new biotechnology company based at Warwick University in the UK, and as a university lecturer. Biophoenix has researched and written over 30 in-depth management/market reports.